STAAR Surgical Company (NASDAQ:STAA) Files An 8-K Submission of Matters to a Vote of Security Holders

ME Staff 8-k
-
0

STAAR Surgical Company (NASDAQ:STAA) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders

The annual meeting of the shareholders of the Company (the “Annual Meeting”) was held on June 14, 2018. 41,612,465 shares of common stock were outstanding on the record date for the Annual Meeting (April16, 2018) and entitled to vote at the Annual Meeting. The voting was as follows:

1. To elect five directors to serve for terms to expire in 2019 or until their successors have been elected and qualified.
Number of Shares
For Withheld Broker Non-Votes
Stephen Farrell 31,713,145 399,881 4,849,874
Caren Mason 31,714,274 398,752 4,849,874
John Moore 31,711,224 401,802 4,849,874
Louis Silverman 31,945,687 167,339 4,849,874
William Wall 31,942,637 170,389 4,849,874
2. To approve the Amended and Restated STAAR Surgical Company Omnibus Equity Incentive Plan.
Number of Shares
For Against Abstain Broker Non-Votes
24,963,510 7,038,291 111,225 4,849,874
3. To adopt amendments to the Amended and Restated Certificate of Incorporation (the “COI”) to make certain changes reflecting current practices in corporate governance and to make certain ministerial and conforming changes.
Number of Shares
For Against Abstain Broker Non-Votes
31,976,217 25,068 111,741 4,849,874
4. To adopt amendments to the Amended and Restated Bylaws (the “Bylaws”) to make certain changes reflecting current practices in corporate governance and to make certain ministerial and conforming changes.
Number of Shares
For Against Abstain Broker Non-Votes
31,974,692 24,468 113,866 4,849,874
5. To adopt amendments to the COI to increase the minimum number of authorized directors from three to five.
Number of Shares
For Against Abstain Broker Non-Votes
31,616,477 391,234 105,315 4,849,874
6. To adopt amendments to the Bylaws to increase the minimum number of authorized directors from three to five.
Number of Shares
For Against Abstain Broker Non-Votes
31,616,752 391,234 105,040 4,849,874
7. To adopt amendments to the COI to reflect that directors may be removed with or without cause.
Number of Shares
For Against Abstain Broker Non-Votes
31,964,949 22,531 125,546 4,849,874
8. To adopt amendments to the Bylaws to reflect that directors may be removed with or without cause.
Number of Shares
For Against Abstain Broker Non-Votes
31,963,299 24,531 125,196 4,849,874
9. To ratify the selection of BDO USA, LLP as the Company’s independent registered public accountants for the fiscal year ending December28, 2018.
Number of Shares
For Against Abstain
36,808,243 142,858 11,799
10. To hold an advisory vote to approve STAAR’s annual compensation program from non-employee directors.
Number of Shares
For Against Abstain Broker Non-Votes
31,546,370 458,186 108,470 4,849,874
11. To hold an advisory vote to approve STAAR’s compensation of its named executive officers.
Number of Shares
For Against Abstain Broker Non-Votes
31,448,047 555,409 109,570 4,849,874


About STAAR Surgical Company (NASDAQ:STAA)

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses (IOLs) used in cataract surgery and implantable collamer lenses (ICLs) used in refractive surgery. It makes lenses used across the world in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). It sells its products in approximately 60 countries, with direct distribution in the United States, Canada, Japan and Spain, and independent distribution in the remainder of the world.